Here's a brief overview of our last funding period (01.07.2020 - 30.06.2024)
Major assets of experimental and preclinical models as well as clinical translation within CRC 1074. HSC, hematopoietic stem cells; LSC, leukemia stem cells; AMLSG, AML Study Group; GCLLSG, German CLL Study Group; I-BFM, International Pediatric Berlin-Frankfurt-Münster Study Group.
